Detalles de la búsqueda
1.
Cognitive Training to Reduce Memory Disturbance Associated With Postoperative Cognitive Impairment After Elective Noncardiac Surgery: An Experimental Study.
J Perianesth Nurs
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573299
2.
Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?
Pharmacol Res
; 196: 106924, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37709185
3.
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
J Neurooncol
; 135(2): 273-284, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28884377
4.
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.
Biomed Pharmacother
; 176: 116857, 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38850664
5.
Screening for epidermal growth factor receptor mutations in lung cancer.
N Engl J Med
; 361(10): 958-67, 2009 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-19692684
6.
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
J Transl Med
; 8: 135, 2010 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21167064
7.
Biomarkers in lung oncology.
Pulm Pharmacol Ther
; 23(6): 508-14, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20471486
8.
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.
Cancers (Basel)
; 11(10)2019 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31614664
9.
Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.
Oncotarget
; 10(26): 2576, 2019 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31069018
10.
Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.
Oncotarget
; 9(43): 27074-27086, 2018 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29930751
11.
Low RAP80 mRNA expression correlates with shorter survival in sporadic high-grade serous ovarian carcinoma.
Int J Biol Markers
; 32(1): e90-e95, 2017 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27443420
12.
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Clin Lung Cancer
; 18(2): 178-188.e4, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27908619
13.
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
J Natl Cancer Inst
; 109(9)2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28376152
14.
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
Clin Cancer Res
; 11(16): 5878-85, 2005 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16115929
15.
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.
Lung Cancer
; 50(1): 25-33, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16011858
16.
Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery.
Clin Lung Cancer
; 6(5): 299-303, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15845181
17.
Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.
Clin Cancer Res
; 10(12 Pt 2): 4215s-4219s, 2004 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15217961
18.
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
JAMA Oncol
; 1(2): 149-57, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26181014
19.
Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients.
Cancer Lett
; 193(2): 207-16, 2003 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-12706879
20.
Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients.
Clin Lung Cancer
; 4(4): 237-41, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14624713